More Relaxation by Deep Breath on Methacholine
SouProvocBro
1 other identifier
observational
78
0 countries
N/A
Brief Summary
Deep inhalation (DI) dilates normal airway precontracted with methacholine. The fact that this effect is diminished or absent in asthma could be explained by the presence of bronchial inflammation. The hypothesis tested was that DI induces more relaxation in methacholine induced bronchoconstriction-solely determined by the smooth muscle contraction-than in exercise induced bronchoconstriction, which is contributed to by both smooth muscle contraction and airway wall inflammation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2006
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2016
CompletedFirst Submitted
Initial submission to the registry
September 21, 2018
CompletedFirst Posted
Study publicly available on registry
October 4, 2018
CompletedOctober 4, 2018
September 1, 2018
10 years
September 21, 2018
September 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Grs change between before deep breath and after deep breath in exercise and metacholine groups
GrsDI represents Grs measured after deep breath reported to Grs before deep breath (bronchial provocation test)
through study completion, an average of 1 hour
Study Arms (2)
test with methacholine
test with exercise
Interventions
Eligibility Criteria
Seventy-three asthmatic children (48 boys) were selected, 37 underwent exercise challenge and 36 methacholine.
You may qualify if:
- Children referred to the lung function department by their pediatric pulmonologist.
- Asthma defined by a complaint of wheezing, cough and dyspnoea.
- Positive response to methacholine or exercise challenge.
- Bronchodilator medications discontinued at least 12 h prior to the testing
- Provocation allowed when the child had been free of respiratory symptoms for at least 2 weeks and baseline FEV1 larger than 70% pred.
You may not qualify if:
- \- Other respiratory diseases than asthma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2018
First Posted
October 4, 2018
Study Start
July 1, 2006
Primary Completion
June 30, 2016
Study Completion
September 30, 2016
Last Updated
October 4, 2018
Record last verified: 2018-09